Affective Disorders Clinical Trial
Official title:
NEURAPAS Balance in Children With Nervous Restlessness, e.g. Agitated Depression
Purpose: To document data on effectiveness of NEURAPAS® balance (NPB) in the treatment of nervous restlessness in children aged 6 to 12. Each patient is treated with NPB. No placebo group is established. Course and severity of symptoms is documented by a questionnaire on 13 common symptoms of nervous restlessness and a Visual Analogue Scale (VAS). A standardized questionnaire (Parent Child Behaviour Checklist (CBCL/4-18)) is completed. Choice and doses of therapy are at the respective physician's discretion. The planned treatment and observation period is 2 - 4 weeks.
Purpose: To document data on effectiveness of NEURAPAS® balance (NPB) in the treatment of nervous restlessness in children aged 6 to 12. Patients and methods: A prospective, non-interventional, non-randomized, observational study conducted in German pediatric practices. Each patient is treated with NPB. No placebo group is established. As subjective criteria to document course and severity of symptoms, a questionnaire on 13 common symptoms of nervous restlessness and a Visual Analogue Scale (VAS) is used. As an objective criterion, a standardized questionnaire (Parent Child Behaviour Checklist (CBCL/4-18)) is completed. Choice and doses of therapy are at the respective physician's discretion. The planned treatment and observation period is 2 - 4 weeks. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03608449 -
Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
|
N/A | |
Completed |
NCT02752295 -
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
|
N/A | |
Completed |
NCT00163865 -
A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents
|
N/A | |
Completed |
NCT03033420 -
Reducing the Rate and Duration of Re-ADMISsions Among Patients With Unipolar Disorder and Bipolar Disorder Using Smartphone-based Monitoring and Treatment - The RADMIS Trials
|
N/A | |
Completed |
NCT03109028 -
Mental Health in Refugees and Asylum Seekers
|
N/A | |
Completed |
NCT03667729 -
The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia
|
N/A | |
Not yet recruiting |
NCT02095457 -
Routine Outcome Monitoring in Mental Health Outpatient
|
N/A | |
Completed |
NCT01815398 -
Cognitive Skills Training for Homeless Youth
|
N/A | |
Completed |
NCT02675257 -
Depression and Diabetes Control Trial
|
N/A | |
Completed |
NCT05379244 -
Better Sleep in Psychiatric Care - Depression, Anxiety and Trauma, Pilot Study
|
N/A | |
Completed |
NCT03335696 -
Predicting MRI Abnormalities With Longitudinal Data of the Whitehall II Substudy
|
||
Completed |
NCT00288782 -
PET Neuroimaging of [11C]Mirtazapine
|
Phase 4 | |
Completed |
NCT00199940 -
Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness
|
Phase 4 | |
Recruiting |
NCT01182012 -
Reduction of Cardiovascular Risk in Severe Mental Illness
|
Phase 4 | |
Completed |
NCT00340379 -
Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
|
Phase 2/Phase 3 |